ROS1 amplification mediates resistance to gefitinib in glioblastoma cells

Glioblastoma (GBM) is the most aggressive brain tumor in adults and remains incurable despite multimodal intensive treatment regimens. The majority of GBM tumors show a mutated or overexpressed EGFR, however, tumors treated with tyrosine kinase inhibitors (TKIs) will inevitably recur highlighting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljohani, Hashim, Koncar, Robert F., Zarzour, Ahmad, Park, Byung Sun, Lee, So Ha, Bahassi, El Mustapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653012/
https://www.ncbi.nlm.nih.gov/pubmed/25978031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653012/
https://www.ncbi.nlm.nih.gov/pubmed/25978031

Ejemplares similares